Key facts
- This page summarizes Amy E. Weaver's Form 4 filing for Salesforce, Inc. (CRM).
- 5 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 18 Dec 2023, 17:14.
Amy E. Weaver - 15 Dec 2023 Form 4 Insider Report for Salesforce, Inc. (CRM)
- Reporting relationship
- President and CFO
- Issuer ticker
- CRM
- Reported as of
- 15 Dec 2023
- Net transaction value
- -$404,404
- SEC form
- 4
- Accepted by SEC
- 18 Dec 2023, 17:14:20 UTC
- Prior SEC filing
- 01 Dec 2023
- Next SEC filing
- 26 Dec 2023
- Source filing
- View source filing
- Reporting owner signature
- /s/ Sarah Dale, Attorney-in-Fact for Amy Weaver
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Amy E. Weaver filed Form 4 for Salesforce, Inc. (CRM) on 18 Dec 2023.
Change
- Previous filing in this sequence was filed on 01 Dec 2023.
- Current net transaction value: -$404,404.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CRM
transaction
Common Stock
Options Exercise
- Transaction value
- $2,151,700
- Shares
- +10,000
- Change %
- +27%
- Price
- $215.17
- Shares after
- 47,048
- Date
- 15 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
CRM
transaction
Common Stock
Sale
- Transaction value
- $1,145,295
- Shares
- -4,500
- Change %
- -9.6%
- Price
- $254.51
- Shares after
- 42,548
- Date
- 15 Dec 2023
- Ownership
- Direct
- Footnotes
- F1
CRM
transaction
Common Stock
Sale
- Transaction value
- $940,609
- Shares
- -3,671
- Change %
- -8.6%
- Price
- $256.23
- Shares after
- 38,877
- Date
- 15 Dec 2023
- Ownership
- Direct
- Footnotes
- F1, F2
CRM
transaction
Common Stock
Sale
- Transaction value
- $470,200
- Shares
- -1,829
- Change %
- -4.7%
- Price
- $257.08
- Shares after
- 37,048
- Date
- 15 Dec 2023
- Ownership
- Direct
- Footnotes
- F1, F3
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CRM
transaction
Derivative
Non-qualified Stock Option (Right to Buy)
Options Exercise
- Transaction value
- $0
- Shares
- -10,000
- Change %
- -18%
- Price
- $0.000000
- Shares after
- 45,508
- Date
- 15 Dec 2023
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 10,000
- Exercise price
- $215.17
- Footnotes
- F1, F4
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Rule 10b5-1 trading plan
These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.
Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).
Explanation of responses 4 footnotes
Footnote F1
As indicated by the checkbox above, this transaction was effected automatically pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 28, 2023.
Footnote F2
Weighted average price. These shares were sold in multiple transactions at prices ranging from $255.8000 to $256.7700 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Footnote F3
Weighted average price. These shares were sold in multiple transactions at prices ranging from $256.8300 to $257.2400 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
Footnote F4
Option vests over four years at the rate of 25% on March 22, 2022, the first anniversary of the holder's date of grant, with the balance vesting in equal monthly installments over the remaining 36 months.